Cannabotech products said to kill “over 90%” of colon cancer cells

Cannabotech products said to kill “over 90%” of colon cancer cells
Cannabis Health News

Estimated reading time: 3 minutes Biomedical cannabis company, Cannabotech, says its products eliminated “over 90 per cent” of colon cancer cells in early studies.  Cannabotech, which is currently developing cancer products based on cannabis and mushroom extracts, has announced cell model study results, showing that its Integrative-Colon products killed over 90 per cent of cancer cells. The study was conducted by Cannabotech’s scientific team, including Professor Tami Peretz, a senior oncologist at Hadassah Ein Kerem Hospital in Israel and Dr Isaac Angel, a pharmacologist specialising in drug development. They examined the effect of Cannabotech’s Integrative Colon products on various colon cancer subtypes, representing common molecular changes in cancer variations. The unique products’ composition was also compared with the activity of each cannabinoid separately. Results showed that Cannabotech’s products were significantly more effective as a composition, than each cannabinoid individually. Cannabotech claims that to achieve effective treatment in the oncology field, it is necessary to build a defined, accurate and science-based formula, which cannot be obtained in any cannabis strain that exists in nature. The study also demonstrated the different effects of each cannabinoid on distinct subtypes of colon cancer, highlighting the need for personalised medical care for patients. The mushroom extracts contain an enriched and high concentration of an active substance called PSK, extracted from the Trametes mushroom, which is known for its anti-cancer properties and has been approved as an oncology treatment in Japan, Taiwan and South Korea. During the next stages of development, the formula’s effectiveness will be examined in combination with standard chemotherapies. The treatment is expected to be launched in Israel, US and the UK in late 2022. Earlier this year, Cannabotech announced that its products designed to target pain and inflammation, reduced symptoms by more than 80 per cent. Professor Peretz, senior oncologist, commented: “Colon…

Excerpt only …
READ MORE BELOW
Source : Cannabotech products said to kill “over 90%” of colon cancer cells

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.